本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Outlook Therapeutics, Inc.

1.48
-0.0500-3.27%
成交量:20.25万
成交额:30.07万
市值:4,827.79万
市盈率:-0.68
高:1.53
开:1.53
低:1.45
收:1.53
数据加载中...
2022/05/31

重要事件披露

8-K - Current report
2022/05/13

重要事件披露

8-K - Current report
2022/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/22

重要事件披露

8-K - Current report
2022/04/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/31

重要事件披露

8-K - Current report
2022/03/25

重要事件披露

8-K - Current report
2022/02/16

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/02/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

重要事件披露

8-K - Current report
2022/02/14

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/02/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/12/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/12/23

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report
2021/12/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/11/29

重要事件披露

8-K - Current report
2021/11/24

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/11/23

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses